Stay updated with breaking news from Functional Changes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Announced positive 12-month topline results from the ARCH open label study of EDG-5506 in adults with Becker muscular dystrophy – – Advancing Phase 2 trial of EDG-5506 in Becker muscular... -Today at 08:03 am- MarketScreener
BOULDER, Colo.--(BUSINESS WIRE)--Jun 26, 2023--
– Sustained positive trend in North Star Ambulatory Assessment (NSAA) scores relative to BMD natural history – – Significant decreases in levels of serum creatine kinase (CK) and fast skeletal muscle troponin I (TNNI2), enzyme biomarkers associated with skeletal muscle damage– – EDG-5506 was well-tolerated at all doses – – Company continuing to enroll patients with BMD in the CANYON Phase 2 trial which now includes a pivotal cohort called GRAND CANYON – – Edgewise leadership to discuss ARCH findings on Tuesday, June 27 at 8:30 a.m. Eastern ...
/PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature...
/PRNewswire/ -- Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products for critically ill, premature...